|
Re: BETonMACE and Aminotransferases
|
4
|
Resverlogix Corp.
|
Aug 14, 2019 05:43PM
|
|
Re: BETonMACE and Aminotransferases
|
4
|
Resverlogix Corp.
|
Aug 14, 2019 07:54PM
|
|
Re: BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency
|
4
|
Resverlogix Corp.
|
Dec 09, 2017 08:00PM
|
|
Re: BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency
|
5
|
Resverlogix Corp.
|
Dec 05, 2017 06:18PM
|
|
Re: BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency
|
4
|
Resverlogix Corp.
|
Dec 05, 2017 06:33PM
|
|
Re: BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency
|
6
|
Resverlogix Corp.
|
Dec 05, 2017 06:42PM
|
|
Re: BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency
|
4
|
Resverlogix Corp.
|
Dec 06, 2017 12:54AM
|
|
Re: BET inhibitors promising therapy for rare pediatric brain tumor
|
4
|
Zenith Epigenetics
|
Feb 28, 2017 06:03PM
|
|
Re: BET inhibitors and Pulmonary Hypertension
|
6
|
Resverlogix Corp.
|
Aug 01, 2018 01:15PM
|
|
Re: BET inhibitors and Pulmonary Hypertension
|
4
|
Resverlogix Corp.
|
Aug 01, 2018 02:18PM
|
|
Re: BET Inhibitors - The next big thing in biotech?
|
3
|
Resverlogix Corp.
|
Nov 22, 2017 04:47AM
|
|
Re: BET inhibitor and BRD4 papers keep piling up
|
5
|
Resverlogix Corp.
|
Sep 25, 2017 01:38PM
|
|
Re: BET and EZH2 Inhibitors: Novel Approaches for Targeting Cancer
|
5
|
Zenith Epigenetics
|
Feb 05, 2019 09:14PM
|
|
Re: Benzinga Interview
|
1
|
Resverlogix Corp.
|
Oct 23, 2021 02:06PM
|
|
Re: Beigene
|
4
|
Resverlogix Corp.
|
May 07, 2019 12:27PM
|
|
Re: Bear....if you could clarify....What's the bottom line?
|
|
Resverlogix Corp.
|
May 22, 2017 12:35PM
|
|
Re: Bear Dsmc
|
4
|
Resverlogix Corp.
|
May 03, 2017 06:14PM
|
|
Re: Bear
|
2
|
Resverlogix Corp.
|
Jul 19, 2020 11:50AM
|
|
Re: Bear
|
2
|
Zenith Epigenetics
|
Apr 17, 2018 02:08AM
|
|
Re: Bear
|
|
Resverlogix Corp.
|
Jul 19, 2020 03:41PM
|
